Publications » 2005 » Publications indexed in Scopus database

Show per page  
11*Sjakste N.; Sjakste T. Nuclear matrix proteins and hereditary diseases. Russ. J. Gen. 2005, 41(3), 221-226.      

12Dirnens V.; Belyakov S.; Lukevics E. Addition of nitrile oxides to N-allylsaccharin. Chem. Heterocycl. Compd. 2005, 41(3), 393-399.      

13Baumane L.; Krauze A.; Belyakov S.; Sile L.; Chernova L.; Griga M.; Duburs G.; Stradiņš J. Synthesis, structure, and electrochemical characteristics of 4-aryl-2-carbamoylmethylthio-5-ethoxycarbonyl-1,4-dihydropyridine-3-carboxylic acid nitriles. Chem. Heterocycl. Compd. 2005, 41(3), 362-373.      

14Williams N.K.; Liepinsh E.; Watt S.J.; Prosselkov P.; Matthews J.M.; Attard P.; Beck J.L.; Dixon N.E.; *Otting G. Stabilization of native protein fold by intein-mediated covalent cyclization. J. Mol. Biol. 2005, 346(4), 1095-1108.      

15*Krauze A.; Sturms I.; Popelis J.; Sile L.; Duburs G. Synthesis and properties of methyl 4,6-diaryl-2(3H)-thioxo-1,4- dihydropyridine-3-carboxylates. Heterocycl. Commun. 2005, 11(1), 37-42.      

16Bisenieks E.; Uldriķis J.; *Duburs G. 3,5-Dicyano-1,4-dihydropyridines as a source for preparation of pyrazole and pyrazolo[3,4-6]pyridine derivatives. Heterocycl. Commun. 2005, 11(1), 9-12.      

17Oakley A.J.; Loscha K.V.; Schaeffer P.M.; Liepinsh E.; Pintacuda G.; Wilce M.C.J.; Otting G.; *Dixon N.E. Crystal and solution structures of the helicase-binding domain of Escherichia coli primase. J. BIOL. CHEM. 2005, 280(12), 11495-11504.      

18*Sjakste N.; Sjakste J.; Boucher J.-L.; Baumane L.; Sjakste T.; Dzintare M.; Meirena D.; Sharipova J.; Kalvinsh I. Putative role of nitric oxide synthase isoforms in the changes of nitric oxide concentration in rat brain cortex and cerebellum following sevoflurane and isoflurane anaesthesia. Eur. J. Pharmacol. 2005, 513(3), 193-205.      

19*Strakova I.; Strakovs A.; Petrova M. Syntheses based on 4-chloro-1-[3,5-di(trifluoromethyl)phenyl]-, 4-chloro-1-(2,4-difluorophenyl)-5-formyl-3-methyl-6,7-dihydroindazoles, and 4-chloro-5-formyl-3-methyl-1-(2-pyridyl)-6,7-dihydroindazoles. Chem. Heterocycl. Compd. 2005, 41(5), 637-646.      

20*Segal I.; Zablotskaya A.; Lukevics E. Silyl modification of biologically active compounds. 10. Lipid type organosilicon derivatives of 8-hydroxyquinoline and n-(2-hydroxyethyl)-1,2,3,4- tetrahydro(sila, iso)quinolines. Chem. Heterocycl. Compd. 2005, 41(5), 613-624.      

Show per page